According to filings with the U.S. Securities and Exchange Commission, Conversio Health is raising up to $16,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Taylor Cline played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Conversio Health
Conversio Health is an innovative chronic condition management company that serves as a key link between the patient, the physician, and the health plan. It has developed a completely new approach for chronic respiratory condition management that combines proprietary technologies and customized nebulizer medication therapies, with a multidisciplinary care team to deliver improved clinical and financial outcomes, and higher patient satisfaction. Its unique, high touch pharmacy model provides home delivery services, personalized patient education and support, and disease progression and medication effectiveness monitoring to prevent unnecessary hospitalizations before they occur. Conversio enables a higher level of care coordination across the care continuum and has a proven track record of lowering its health plan partners drug cost and improving clinical outcomes for thousands of patients with COPD and Asthma across the United States. Conversio Health was founded in 2013 and is headquartered in San Luis Obispo, California.

To learn more about Conversio Health, visit http://conversiohealth.com/

Contact:
Taylor Cline, Chief Executive Officer
866-239-3784
https://www.linkedin.com/in/taylor-cline-b4659335/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.